Pragmatic Use of Kidney Function Estimates for Drug Dosing: The Tide Is Turning.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Advances in Chronic Kidney Disease

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/j.ackd.2017.10.003PMID 29499882
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines

  2017cited by this paper
• Discrepancies between the Cockcroft–Gault and Chronic Kidney Disease Epidemiology (CKD-EPI) Equations: Implications for Refining Drug Dosage Adjustment Strategies

  2017cited by this paper
• Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.

  2017cited by this paper
• New Model for Estimating Glomerular Filtration Rate in Patients With Cancer

  2017cited by this paper
• Older Adult Kidney Function Assessment and Rounding Creatinine Led to Medication Dosing Error

  2017cited by this paper
• Metabolically Healthy Obesity and Development of Chronic Kidney Disease

  2016cited by this paper
• Aging and the Kidneys: Anatomy, Physiology and Consequences for Defining Chronic Kidney Disease

  2016cited by this paper
• Harmonization of Renal Function Assessment Is Needed During Early Clinical Development of Oncology Drugs.

  2016cited by this paper
• Creatinine-based equations for the adjustment of drug dosage in an obese population.

  2016cited by this paper
• Drug therapy management in patients with renal impairment: how to use creatinine-based formulas in clinical practice

  2016cited by this paper
• Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.

  2015cited by this paper
• Estimated glomerular filtration rate leads to higher drug dose recommendations in the elderly compared with creatinine clearance

  2015cited by this paper
• Removal of body surface area normalisation improves raw‐measured glomerular filtration rate estimation by the Chronic Kidney Disease Epidemiology Collaboration equation and drug dosing in the obese

  2015cited by this paper
• Influence of Renal Function Estimation on Pharmacokinetic Modeling of Vancomycin in Elderly Patients

  2015cited by this paper
• The performance of contemporary cystatin C-based GFR equations in predicting gentamicin clearance.

  2015cited by this paper
• Prevalence of Obesity Among Adults and Youth: United States, 2011-2014.

  2015cited by this paper
• The method of GFR determination impacts the estimation of cisplatin eligibility in patients with advanced urothelial cancer

  2014cited by this paper
• Estimation of Glomerular Filtration Rate to Adjust Vancomycin Dosage in Critically Ill Patients: Superiority of the Chronic Kidney Disease Epidemiology Collaboration Equation?

  2014cited by this paper
• Glomerular Filtration Rate Equations Overestimate Creatinine Clearance in Older Individuals Enrolled in the Baltimore Longitudinal Study on Aging: Impact on Renal Drug Dosing

  2013cited by this paper
• Two Novel Equations to Estimate Kidney Function in Persons Aged 70 Years or Older

  2012cited by this paper
• Impact of Various Body Weights and Serum Creatinine Concentrations on the Bias and Accuracy of the Cockcroft‐Gault Equation

  2012cited by this paper
• A Systematic Comparison of Cockcroft-Gault and Modification of Diet in Renal Disease Equations for Classification of Kidney Dysfunction and Dosage Adjustment

  2012cited by this paper
• Estimating glomerular filtration rate from serum creatinine and cystatin C.

  2012cited by this paper
• Simplified Estimation of Aminoglycoside Pharmacokinetics in Underweight and Obese Adult Patients

  2011cited by this paper
• Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

  2011cited by this paper
• Comparative Evaluation of the Cockcroft‐Gault Equation and the Modification of Diet in Renal Disease (MDRD) Study Equation for Drug Dosing: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy

  2011cited by this paper
• Agreement between equations estimating glomerular filtration rate in elderly nursing home residents and in hospitalised patients: implications for drug dosing.

  2011cited by this paper
• Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2.

  2010cited by this paper
• Estimating the glomerular filtration rate in obese adult patients for drug dosing.

  2010cited by this paper
• A new equation to estimate glomerular filtration rate.

  2009cited by this paper
• Estimation of creatinine clearance in morbidly obese patients.

  2009cited by this paper
• Comparison of the Modification of Diet in Renal Disease and Cockcroft‐Gault Equations for Dosing Antimicrobials

  2009cited by this paper
• Rapid evaluation of creatinine clearance.

  2009cited by this paper
• Use of the MDRD Study Equation to Estimate Kidney Function for Drug Dosing

  2009cited by this paper
• The State of aging and health in America 2007

  2007cited by this paper
• Evaluation of the modification of diet in renal disease study equation in a large diverse population.

  2007cited by this paper
• Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

  2006cited by this paper
• Quantification of Lean Bodyweight

  2005cited by this paper
• Creatinine measurement: state of the art in accuracy and interlaboratory harmonization.

  2005cited by this paper
• A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation

  1999cited by this paper
• Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

  1989cited by this paper
• Prediction of Creatinine Clearance from Serum Creatinine

  1976cited by this paper
• Prediction of creatinine clearance from serum creatinine.

  1975cited by this paper
• Drug dosage in patients with renal disease

  1974cited by this paper
• Letter: Creatinine clearance: bedside estimate.

  1973cited by this paper
• Creatinine Clearance: Bedside Estimate

  1973cited by this paper
• Endogenous Creatinine Clearance as a Clinical Measure of Glomerular Filtration Rate*

  1971cited by this paper
• Rapid evaluation of creatinine clearance.

  1971cited by this paper
• A practical guide to drug usage in adult patients with impaired renal function.

  1970cited by this paper
• Drug dosage in patients with impaired renal function.

  1970cited by this paper
• A guide to use of antibiotics in patients with renal disease. A table of recommended doses and factors governing serum levels.

  1967cited by this paper
• Persistence of antibiotics in blood of patients with acute renal failure. I. Tetracycline and chlortetracycline.

  1959cited by this paper
• Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.

  1959cited by this paper
• Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.

  1959cited by this paper

• Aligning kidney function assessment in patients with cancer to global practices in internal medicine

  2025cites this paper
• CORRELATION OF CLINICAL LABORATORY PARAMETERS AND DEMOGRAPHY WITH PHARMACOKINETICS OF TACROLIMUS – A NARROW THERAPEUTIC INDEX DRUG

  2025cites this paper
• Inadequate imipenem dosing in patients with decreased kidney function: A clinical pharmacokinetic study.

  2025cites this paper
• Impact of Removing Race Coefficient from Glomerular Filtration Rate Estimation Equations on Antidiabetics Among Black Patients

  2025influential citation
• A methodology for determining dosing recommendations for anticancer drugs in patients with reduced kidney function

  2025cites this paper
• Contemporary considerations for nephrotoxin stewardship: Estimating kidney function and use of novel biomarkers

  2024influential citation
• Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients.

  2024cites this paper
• KDOQI US Commentary on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD.

  2024cites this paper
• Association between Area under the Curve Estimated from Carboplatin Dose and Incidence of Severe Thrombocytopenia in Patients with Non-Hodgkin’s Lymphoma on DeVIC Therapy

  2023cites this paper
• AACC/NKF Guidance Document on Improving Equity in Chronic Kidney Disease Care.

  2023cites this paper
• The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage

  2023cites this paper
• Estimating kidney function in patients with cancer: A narrative review

  2023cites this paper
• Medication-related adverse events in patients with cancer and discrepancies in cystatin C- versus creatinine-based eGFR

  2023cites this paper
• Sarcopenia, adiposity, and discrepancies in cystatin C versus creatinine-based eGFR in patients with cancer: a cross-sectional study

  2023cites this paper
• Advances in the management of chronic kidney disease

  2023cites this paper
• Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022

  2023cites this paper
• Paradoxical mortality of high estimated glomerular filtration rate reversed by 24‐h urine creatinine excretion rate adjustment: sarcopenia matters

  2022cites this paper
• Principles for the Prevention of Medication-Induced Nephrotoxicity.

  2022cites this paper
• Evaluating the usefulness of the estimated glomerular filtration rate for determination of imipenem dosage in critically ill patients.

  2022cites this paper
• Serum cystatin C level can be used to estimate GFR in patients with solid tumors: Moderator Commentary

  2022cites this paper
• Effect of kidney disease on pharmacokinetics

  2022cites this paper
• Cancer Drug Dosing in Chronic Kidney Disease and Dialysis.

  2022cites this paper
• Antimicrobial safety considerations in critically ill patients: part I: focused on acute kidney injury

  2022cites this paper
• Kidney Function Assessment in African American Patients: A Narrative Review for Pharmacists

  2022cites this paper
• Circulation: Cardiovascular Quality and Outcomes

  2021cites this paper
• Antibiotic dosing adjustments in hospitalized patients with chronic kidney disease: a retrospective chart review

  2021cites this paper
• Deviant Dosing: A Post hoc Analysis of Pharmacist Characteristics Related to Renal Dosing Decisions

  2021cites this paper
• Renal Function Assessment and Direct-Acting Oral Anticoagulants Dosing: Are We Entering a New Age?

  2021cites this paper
• Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum.

  2021cites this paper
• Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participants.

  2021cites this paper
• Evaluación de la función renal para la detección y seguimiento de la enfermedad renal crónica. Documento multidisciplinario de consenso 2021. Especial atención sobre situaciones clínicas específicas

  2021cites this paper
• 369 Patterns of Cystatin C Uptake and Utilization Across and Within Hospitals

  2020cites this paper
• GFR Measurement and Chemotherapy Dosing in Patients with Kidney Disease and Cancer.

  2020cites this paper
• How to assess kidney function in oncology patients.

  2020cites this paper
• Cystatin C: A Primer for Pharmacists

  2020cites this paper
• Psychopharmacologic treatment

  2020cites this paper
• Drug dosing in cancer patients with decreased kidney function: A practical approach.

  2020cites this paper
• Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic

  2020cites this paper
• Dose Optimization in Kidney Disease: Opportunities for PBPK Modeling and Simulation

  2020cites this paper
• Drug-Induced Nephrotoxicity

  2020cites this paper
• Current progress in identifying endogenous biomarker candidates for drug transporter phenotyping and their potential application to drug development.

  2020cites this paper
• Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein‐Mediated Drug‐Drug Interactions in Healthy Volunteers

  2020cites this paper
• Patterns of Cystatin C Uptake and Use Across and Within Hospitals.

  2020cites this paper
• Correct use of non-indexed eGFR for drug dosing and renal drug-related problems at hospital admission

  2020cites this paper
• Renal Medicine and Clinical Pharmacy

  2020influential citation
• The Impact of Multiple Renal Estimates on Pharmacist Dosing Recommendations: A Randomized Trial

  2020cites this paper
• Predictors of Augmented Renal Clearance in a Heterogeneous ICU Population as Defined by Creatinine and Cystatin C

  2020cites this paper
• Clearance Confusion: An Exploratory Analysis of Inpatient Dosing Discordances Between Renal Estimating Equations

  2020cites this paper
• Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and Dosing.

  2019influential citation
• Quality use of medicines in patients with chronic kidney disease

  2019cites this paper
• Prediction Of Serum Digoxin Concentration Using Estimated Glomerular Filtration Rate In Thai Population

  2019cites this paper
• A Reflex Protocol for Creatinine Testing Reduces Costs and Maintains Patient Safety.

  2018cites this paper